⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Ibuprofen lysine IV (neonatal)
ایبوپروفن لیزین وریدی (نوزاد)
❤️ Cardiovascular SystemNSAID for PDA closure
👶 Children:Use with caution 🇮🇷 Not found in Iran list⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA021903ATC C01EB16
Market / country: 🇺🇸 USA
NeoProfen (US)
🧮 Dose calculator
Patent ductus arteriosus (preterm) · Regimen source: FDA NeoProfen · 2.1
- • Doses by birth weight. Withhold the 2nd/3rd dose if anuria or oliguria (<0.6 mL/kg/h) until renal function normalises. Dilute and infuse over 15 min. FDA NeoProfen · 2.1FDA NeoProfen · 2.2
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Untreated infection; ductal-dependent congenital heart disease; active bleeding (intracranial or GI); thrombocytopenia; coagulation defects; NEC; significant renal impairment. FDA NeoProfen · 4
Formulations
- 10 mg/mL (20 mg/2 mL) vial — injection 🇺🇸 USA FDA NeoProfen · 3
👥 Special populations
- 🤰 PregnancyNo data
The source for this drug has no section for this group.
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA NeoProfen · 8.4
“Safety and effectiveness have only been established in premature infants.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA021903
- DailyMed (FDA label)FDA NeoProfen
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDC01EB16
- Darooyab (Iran)❌ None
🇮🇷 Not found in Iran list Darooyab · search
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA NeoProfen · 3FDA NeoProfen · 2.1FDA NeoProfen · 2.2FDA NeoProfen · 4FDA NeoProfen · 8.4FDA NeoProfen · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · search
- Clinical review⚠ Unverified